Evidence map›Paper›PMID 33983997›Full record

ArticlePloS one2021

Effectiveness of thermal screening in detection of COVID-19 among truck drivers at Mutukula Land Point of Entry, Uganda.

Andrew Nsawotebba, Ivan Ibanda, Isaac Ssewanyana, Patrick Ogwok, Francis Ocen, Christopher Okiira, Atek Kagirita, Dennis Mujuni, Didas Tugumisirize, Joel Kabugo and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Andrew NsawotebbaDepartment of National Health Laboratory and Diagnostic Services, Ministry of Health, Kampala, Uganda.ORCID 0000-0002-5452-3603
Ivan IbandaDepartment of National Health Laboratory and Diagnostic Services, Ministry of Health, Kampala, Uganda.
Isaac SsewanyanaDepartment of National Health Laboratory and Diagnostic Services, Ministry of Health, Kampala, Uganda.
Patrick OgwokDepartment of National Health Laboratory and Diagnostic Services, Ministry of Health, Kampala, Uganda.
Francis OcenAfrica Centres for Disease Control and Prevention/African Society for Laboratory Medicine, Addis Ababa, Ethiopia.
Christopher OkiiraUganda National Health Laboratory Services, Kampala, Uganda.
Atek KagiritaMinistry of Health, Kampala, Uganda.
Dennis MujuniCollege of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda.ORCID 0000-0002-7831-2894
Didas TugumisirizeTuberculosis and Leprosy Control Division, Ministry of Health, Kampala, Uganda.
Joel KabugoUganda National Tuberculosis Reference Laboratory /Supranational Reference Laboratory, Ministry of Health, Kampala, Uganda.ORCID 0000-0002-5666-9702
Abdunoor NyombiUganda National Tuberculosis Reference Laboratory /Supranational Reference Laboratory, Ministry of Health, Kampala, Uganda.
Robert Kaos MajwalaTuberculosis and Leprosy Control Division, Ministry of Health, Kampala, Uganda.
Bernard Ssentalo BagayaDepartment of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
Simeon Kalyesubula-KibuukaUganda National Health Laboratory Services, Kampala, Uganda.ORCID 0000-0002-9208-5675
Willy SsengoobaDepartment of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
Susan NabaddaDepartment of National Health Laboratory and Diagnostic Services, Ministry of Health, Kampala, Uganda.
Ministry of Health · UGMakerere University · UGAfrica Centres for Disease Control and Prevention · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite the limited evidence for its effectiveness, thermal screening at points of entry has increasingly become a standard protocol in numerous parts of the globe in response to the COVID-19 pandemic. We sought to determine the effectiveness of thermal screening as a key step in diagnosing COVID-19 in a resource-limited setting. MATERIALS AND

methodsThis was a retrospective cross-sectional study based on a review of body temperature and Xpert Xpress SARS CoV-2 test results records for truck drivers entering Uganda through Mutukula between 15th May and 30th July 2020. All records missing information for body temperature, age, gender, and Xpert Xpress SARS CoV-2 status were excluded from the data set. A data set of 7,181 entries was used to compare thermal screening and Xpert Xpress SARS CoV-2 assay test results using the diagnostic statistical test in STATAv15 software. The prevalence of COVID-19 amongst the truck drivers based on Xpert Xpress SARS CoV-2 assay results was determined. The sensitivity, specificity, positive predictive value, negative predictive value, positive and negative Likelihood ratios were obtained using Xpert Xpress SARS CoV-2 assay as the gold standard.

resultsBased on our gold standard test, the proportion of persons that tested positive for COVID-19 was 6.7% (95% CI: 6.1-7.3). Of the 7,181 persons that were thermally screened, 6,844 (95.3%) were male. The sample median age was 38 years (interquartile range, IQR: 31-45 years). The median body temperature was 36.5°C (IQR: 36.3-36.7) and only n (1.2%) had a body temperature above 37.5°C. The sensitivity and specificity of thermal screening were 9.9% (95% CI: 7.4-13.0) and 99.5% (95% CI: 99.3-99.6) respectively. The positive and negative predictive values were 57.8 (95% CI: 46.5-68.6) and 93.9 (95% CI: 93.3-94.4) respectively. The positive and negative Likelihood Ratios (LRs) were 19 (95% CI: 12.4-29.1) and 0.9 (95% CI: 0.88-0.93) respectively.

conclusionIn this study population, the use of Thermal screening alone is ineffective in the detection of potential COVID-19 cases at point of entry. We recommend a combination of screening tests or additional testing using highly sensitive molecular diagnostics such as Polymerase Chain Reaction.

Indexed as

AdultBody TemperatureCOVID-19Cross-Sectional StudiesFemaleHumansMaleMass ScreeningMiddle AgedPredictive Value of TestsRetrospective StudiesSARS-CoV-2UgandaYoung Adult

Identifiers

PMID33983997
PMCPMC8118319
OpenAlexW3163570493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.